Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 71 entries
View as:

Use of Cefiderocol in the Management of Gram-Negative Infections

Phase: N/A Priority: Normal
NCT ID: NCT05789199 Org: User:
Start: 07/31/22 End: 06/16/23 Due: 06/16/24

A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01443403 Org: User:
Start: 08/17/11 End: 08/22/12 Due: 08/22/13

Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00491894 Org: User:
Start: 03/31/07 End: 06/30/08 Due: 06/30/09

A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00276094 Org: User:
Start: 01/31/06 End: 12/31/07 Due: 12/31/08

Long Term Safety of Naldemedine

Phase: N/A Priority: Normal
NCT ID: NCT01965652 Org: User:
Start: 09/24/13 End: 01/12/16 Due: 01/12/17

Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04147715 Org: User:
Start: 10/09/19 End: 09/29/20 Due: 09/29/21

A Study to Assess the Effects of BPN14770 on Rosuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT07011992 Org: User:
Start: 06/09/25 End: 07/27/25 Due: 07/27/26

Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls

Phase: N/A Priority: Normal
NCT ID: NCT07012005 Org: User:
Start: 06/03/25 End: 12/31/25 Due: 12/31/26

Safety and Efficacy Study of S-309309 in Obese Adults

Phase: N/A Priority: Normal
NCT ID: NCT05925114 Org: User:
Start: 06/21/23 End: 05/17/24 Due: 05/17/25

A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05363215 Org: User:
Start: 08/10/22 End: 04/12/23 Due: 04/12/24

First-in-human Study of S-588210 (S-488210+S-488211)

Phase: N/A Priority: Normal
NCT ID: NCT04316689 Org: User:
Start: 07/30/19 End: 09/22/21 Due: 09/22/22

A Study of S-740792 in Healthy Adult Study Participants

Phase: N/A Priority: Normal
NCT ID: NCT06724978 Org: User:
Start: 11/21/24 End: 09/16/25 Due: 09/16/26

Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01965158 Org: User:
Start: 08/29/13 End: 01/22/15 Due: 01/22/16

Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

Phase: N/A Priority: Normal
NCT ID: NCT02714595 Org: User:
Start: 09/07/16 End: 04/22/19 Due: 04/22/20

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

Phase: N/A Priority: Normal
NCT ID: NCT05897541 Org: User:
Start: 06/09/23 End: 09/18/24 Due: 09/18/25

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT05953480 Org: User:
Start: 07/14/23 End: 03/31/26 Due: 03/31/27

A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

Phase: N/A Priority: Normal
NCT ID: NCT05409911 Org: User:
Start: 09/13/22 End: 04/25/23 Due: 04/25/24

A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00697710 Org: User:
Start: 07/31/07 End: 09/30/08 Due: 09/30/09

Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01122030 Org: User:
Start: 05/19/10 End: 03/22/11 Due: 03/22/12

A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT02321800 Org: User:
Start: 02/05/15 End: 08/16/16 Due: 08/16/17

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications

Phase: N/A Priority: Normal
NCT ID: NCT02949011 Org: User:
Start: 01/11/17 End: 04/20/18 Due: 04/20/19

Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet

Phase: N/A Priority: Normal
NCT ID: NCT00748605 Org: User:
Start: 06/30/07 End: 01/31/09 Due: 01/31/10

Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT03862040 Org: User:
Start: 02/20/19 End: 10/15/19 Due: 10/15/20

A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza

Phase: N/A Priority: Normal
NCT ID: NCT02954354 Org: User:
Start: 12/08/16 End: 04/24/17 Due: 04/24/18

Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids

Phase: N/A Priority: Normal
NCT ID: NCT05588323 Org: User:
Start: 01/04/23 End: 06/15/26 Due: 06/15/27